9Kannel WB, Cupples LA,D Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J, 1987,113:799.
10Wachtell K,Okin PM,Olsen MH. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study. Circulation, 2007,116: 700-705.
4Arzamendi D, Benito B, Tizon-Marcos H, et al. Increase in sudden death from coronary artery disease in young adults[ J]. Am Heart J, 2011, 161:574-580.
5Obias-Manno D, Wijetunga M. Risk stratification and primary prevention of sudden cardiac death: sudden death prevention[ J]. AACN Clin Issues, 2004, 15: 404-418.
6Virmani R, Burke AP, Farb A. Sudden cardiac death [ J ]. Cardiovase Pathol, 2001, 10:275-282.
7Sen-Chowdhry S, McKenna WJ. The utility of magnetic resonance imaging in the evaluation of arrhythmogenic right ventricular cardiomyopathy[ J]. Curr Opin Cardiol, 2008, 23:38-45.
8Couzigou P. [Practitioner blindness? Lifestyle medicine is a reality! Screening without prevention, rational?] [J]. Presse Med,2013 ;42 (12) : 1551-1554.
9Sorensen H J. A conversation on the future of health care: integrating lifestyle medicine-part one: under- standing the concepts [J]. Perm J,2014;18 (2): 89-91.
10Savarimuthu S M, Jensen A E, Schoenthaler A, et al. Developing a toolkit for panel management :improv- ing hypertension and smoking cessation outcomes in primary care at the VA [J]. BMC Fam Pract,2013; 14: 176.
